LOGO
LOGO

Adaptive Biotechnologies Q1 Loss decreases, beats estimates

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Adaptive Biotechnologies (ADPT) reported Loss for first quarter that decreased from last year and beat the Street estimates.

The company's earnings came in at -$47.5 million, or -$0.33 per share. This compares with -$57.7 million, or -$0.40 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$0.34 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 11.4% to $41.9 million from $37.6 million last year.

Adaptive Biotechnologies earnings at a glance (GAAP) :

-Earnings (Q1): -$47.5 Mln. vs. -$57.7 Mln. last year.
-EPS (Q1): -$0.33 vs. -$0.40 last year.
-Revenue (Q1): $41.9 Mln vs. $37.6 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19